STOCK TITAN

[6-K] Marex Group plc Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Analyzing...
Positive
  • None.
Negative
  • None.
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-42020

 

 

MAREX GROUP PLC

(Translation of registrant’s name into English)

 

 

 

155 Bishopsgate

London EC2M 3TQ

United Kingdom

+44 20 7655 6000

 

140 East 45th Street, 10th Floor

New York, New York 10017

(212) 618-2800

(Address of Principal Executive Offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

 

 
 


EXPLANATORY NOTE

Marex Group plc Preliminary Q3 2025 Update

On 8 October 2025, Marex Group plc (the “Company”) issued a press release titled “Marex Group plc provides a strong preliminary Q3 trading update”. A copy of the press release is furnished as Exhibit 99.1 herewith.


EXHIBIT INDEX

The following exhibit is furnished as part of this Form 6-K:

 

Exhibit No.    Description
99.1    Press release dated 8 October 2025 titled “Marex Group plc provides a strong preliminary Q3 trading update”


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Marex Group plc
Date: 8 October 2025     By:   /s/ Robert Irvin
      Robert Irvin
      Chief Financial Officer
Marex Group plc

NASDAQ:MRX

MRX Rankings

MRX Latest News

MRX Latest SEC Filings

MRX Stock Data

2.06B
54.86M
24.78%
69.57%
3.33%
Capital Markets
Financial Services
Link
United Kingdom
London